SlideShare a Scribd company logo
HEMATOLOGICAL
MANIFESTATIONS OF HIV-AIDS
Maj Shilpi Singh
Guide: Col Sonia Badwal
• A 48-year-old woman
• Presentation
– severe epistaxis.
– hematologic profile
• marked thrombocytopenia (3 x 109/L)
• hemoglobin 11.6 g/dL,
• leukocyte count 5.2 x 109/L
• unremarkable blood film except for rare platelets.
– tested positive for HIV
• CD4 count was low (20/mm3).
– tentative diagnosis HIV–immune thrombocytopenic
purpura (ITP)
– treated with
• antiretroviral medications,
• IVIG,
– No improvement.
– After 6 weeks bone marrow examination done.
• The aspirate was dry.
– core biopsy
• hypercellular marrow with heavy infiltrate of
Mycobacterium avium intracellulare infection
– started on 4-drug antituberculosis treatment,
– 2 weeks later her platelet count was 30 x 109/L.
– platelet count steadily rose to 150 x 109/L by
day 20 and was maintained thereafter
CASE 2 AFMC NOV 2008
26 yr old lady presented with Fever , Low
backache and significant weight loss with
past history of cervical Lymphadenitis &
exposure to ATT( 2006) .
Spleen palpable 03cm below LCM ,firm, non tender
• Hb - 10.3gm/dl
• TLC - 7600 / cumm
• DLC - P 68L24 M03 E 05
• Platelets - 2.3 x 106
/ μL
• PBS - Microcytic hypochromic picture
• ESR (wg) - 18mm fall in 1st
hr
• Spinal Abnormality, kyphosis and gibbus
abnormalities present
• Put on ATT again at Kolhapur
• Presented to us in Nov 2008 with severe
pancytopenia requiring multiple
transfusions
• BM asp BM biopsy suggestive of anaemia
of critically ill and showed florid gelatinous
degeneration
• Thus tested for HIV and found to be
positive
What is AIDS
• an HIV infection
• any of the disorders in clinical category B or C of
HIV infection.
– Serious opportunistic infections
– cancers, such as Kaposi's sarcoma and non-Hodgkin
lymphoma, to which defective cell-mediated immunity
predisposes
– Neurologic dysfunction
• or a CD4+ T lymphocyte count of < 200/μL.
CDC disease staging system (most recently revised in 1993)
Contents
• Hematological Manifestations.
• BM Manifestations.
• HIV associated lymphomas.
Hematological Manifestations
• Cytopenias
– Anaemia
– Neutropenia
– Thrombocytopenia
• Thrombotic thrombocytopenic purpura.
• Coagulopathies and coagulation disorders
Anaemia
• Most common.
• Throughout the course of illness.
• ART can cause improvement in Hb levels.
• Increased risk of disease progression.
• Shorter survival.
• Decreased quality of life.
Etiopathogenesis
• HIV induced effect on bone marrow.
– Ineffective erythropoesis.
– Infection of progenitor cells.
– Negative effect on EPO.
• Nutritional deficiency.
– Fe, B12, Folate.
• Infiltration of BM- infections or tumors.
• Medications.
Etiopathogenesis (contd)
• Hemolytic anaemia.
– Intrinsic red cell defect
– Extrinsic red cell defect DCT positive
• Both warm and cold AIHA.
• Increased risk of thromboembolism.
• Thrombocytopenia and fragmented cells in PBS.
• Bleeding.
– GI bleeding due to CMV, NHLs and kaposi.
Lab investigations
• PBS-
– Macrocytosis due to AZT.
– Normocytic due to HIV infection.
– Schistocytes .
• Fe indices-
– Low serum Fe and transferrin and high serum
ferritin.
– BM Fe increased
Lab investigations (contd)
• Positive DAT-
– 20-43% of hospitalised patients of AIDS.
– Cold agglutinins in 22%.
• B12 levels low.
• Folate levels are normal.
• EPO levels are-
– Low due to post-translational events.
– High in patients with zidovudine associated
anaemia.
Leukopenia
• Lymphopenia and neutropenia commonly.
• Impaired granulopoesis.
• Neutropenia due to drugs-
– Pentamidine, gancyclovir, zidovudine.
• Autoimmune distruction.
• PBS –
– hypopigmentation, shift to left, pseudo-pelger huet and
other dysplastic changes.
• Neutrophil function abnormalities.
Thrombocytopenia
• <100,000/mm3.
• 3-8% of HIV positive and 30-45% of AIDS.
• Neither a prognostic indicator nor a sign for
progression.
• Any stage of disease.
• Rarely significant bleeding problem.
• Responds to ART.
Etiopathogenesis
• Platelet destruction in early course.
• Reduced production in later course.
• Causes-
– Chronic ITP-megakaryocytic .
• Elevated platelet associated antibodies. GpIIIa
• Cross reactivity between anti-HIV and platelet antigens.
– Impaired thrombopoesis-
• Depressed marrow platelet production.
• Low MPV and dyspoetic
– Drug induced
TTP
• Pentad of fever, neurological deficit,
thrombocytopenia, oliguria and
microangiopathy.
• PBS-schistocytes, reticulocytosis.
• Indirect hyperbilirubinaemia, raised LDH.
• Precipitated by-infection, drugs, pregnancy
etc.
• More in era before HAART.
Etiopathogenesis
• Absence of vWF cleaving protease activity.
• In HIV the cause is IgG autoantibody against
the enzyme.
• Common coexistence of AIDS defining
illnesses.
• CD4+<250/mm3.
• TTP should always be in the list.
Coagulation Disorders
• HIV is a prothrombotic condition.
• Low CD4+ count and protease inhibitors
are the culprits.
• Coexistent-APLA, LA, Protein C and S
deficiency, malignancies, autoimmune
disorders.
• Endothelial damage due to tumor cells.
Other coagulation protein
abnormalities
• Heparin cofactor II deficiency.
• AT deficiency is reported in HIV patients-
– Malnutrition
– Protein loosing nephropathy.
• Prevalance
– LA=53-70%
– anti-cardiolipin antibodies=46-90%.
• Infections like Hep C, syphilis, PCP cause
production of antibodies.
Role of protease inhibitors
• Abnormalities of glucose metabolism and
serum lipids.
• Disturbances of fibrinolysis.
•BONE MARROW
MANIFESTATIONS OF
HIV
Bone Marrow
• Cytological features
– M/E ratio 2-5:1
– Hypercellular,
– normocellular or hypocellular
– Erythroid dysplasia
– Erythroid hypoplasia
• MAC infection,
Bone Marrow
• Myeloid dysplasia
– Left-shifted,
– hyposegmented,
– maturation arrest at metamyelocyte stage
• Megakaryocytes
– Adequate to increased
– Dysplastic
– hyposegmented,
– Micro megakaryocytes denuded nuclei.
Bone Marrow
• Plasmacytosis
• Lymphoid aggregates/infiltrates
• Histiocytes
• “Loose granulomas” (aggregates of plasma
cells, lymphocytes, histiocytes)
• Erythrophagocytosis
Bone Marrow
• Increased eosinophils
• Iron adequate to increased (reticulo-
endothelial cell distribution)
• Marrow Increased reticulin
• Matrix Necrosis
• Serous atrophy
Etiopathogenesis
• Infection of MSCs with HIV-
– Abrogates growth
– Hematopoetic supportive function.
• Defective progenitor growth-
– Secondary to suppressor T-cell.
– Inversely proportional to T4 to T8 ratio.
• CD34 progenitor cell – infected with HIV.
Etiopathogenesis
• HIV infection of Monocyte/Macrophage-
– Exaggerated TNF, IL-1 and TGF-b
– Development of immunodeficiency.
– HIV-1 dementia.
• HIV infection of microvascular endothelial
cells-
– Poor response to IL-1a.
– Impaired release of IL-6 and G-CSF
Dyserythropoesis
• Most common, includes-
– Changes in erythroblasts –
• Lobulations
• Binucleation and fragmentation-
• Basophilic stippling in later stages.
• Florid megaloblastic changes
• Unrelated to B12, folate and drugs.
– Erythroid hypoplasia-
• In AIDS, ARC, Ziduvudine and MAC infection.
• PRCA secondary to parvovirus B19.
Dyserythropoesis
Dysmegakaryopoesis
• Can be with or without thrombocytopenia.
• Dysplastic changes-
– Micromegs with denuded nuclei
– Hyposegmented megs
– Fragmented nuclei
– Clustering of megs.
• Dysplastic changes and presence of HIV RNA
in megs
Cellularity
• BM is difficult to aspirate.
– Focal or diffuse increase in reticulin
• Normo to hypercellular.
– Myeloid dysplasia
– Ineffective erythropoesis
• M:E ratio of 2-7:1
– Myeloid hyperplasis
– Erythroid hypoplasia.
Plasma cell abnormalities
• Increase seen in 31-85% people.
• Due to-
– Physiological response to antigenic stimulation.
– Dysregulated B-cell proliferation.
– Seen in all stages.
• Morphology
– Dysplasia, large bi or tri nucleate
– In clusters
Plasma cell abnormalities
• Russel bodies, multiple globules.
• Myeloma is clearly reported in AIDS.
• Monoclonal spikes on serum electrophoresis.
• Marrow plasmacytosis
• Atypical forms.
• Without demonstration of clonality.
• Paraproteinemia
activity against HIV gag & pol
Vigrous immune response to HIV.
Lymphoid aggregates
• 10-50% of patients of AIDS-ARC.
• Small, round, well circumscribed- small
lymphocytes.
• Large poorly defined mixed with histiocytes.
• Atypical, cleaved lymphocytes-paratrabecular
•HIV ASSOCIATED
LYMPHOMA
Lymphoma
• 80% peripheral, 20% arise in CNS.
• Aggressive B-cell lymphoma.
• PCNSL
• Primary effusion Lymphoma.
• Plasmblastic multicentric Castleman disease.
• Hodgkin Lymphoma.
Why HIV- Associated
• Sharp decline post HAART
• Similar geographic distribution
• Same risk group individuals
• Not responding to chemo as other lymphomas
• More extranodal spread , BM commonest
HIV –associated lymphomas
• Co-infection with HIV and KSHV/HHV-8
• Liquid phase
• No masses or adenopathy
• Fever, night sweats, weight loss and
hepatosplenomegaly.
Aggressive B-cell lymphomas
• DLBCL
• B-cell immunoblastic lymphomas
• Small non-cleaved lymphoma
– Burkitt
– Burkitt-like.
Plasmablastic lymphoma
• Cells resemble B-immunoblasts
• Immunphenotypically plasma cells
• Highest incidence in HIV-patients
• Mass in oral cavity, extranodal sites
• Diffuse and cohesive proliferation
• EBV associated
• CD 38,138 positive-CD 45,20 negative.
PCNSL
• CD4< 50.
• Also large cell lymphomas
• EBV associated
• Lack c-myc translocation
• Responds well to HAART.
HIV associated HD
• HD not a part of CDC definition
• More aggressive, extranodal, BM involvment
• Less mediastinal adenopathy
• Mixed cellularity or LDHL
• CD4< 300/dl
Lymphoma
ROLE OF FLCs
• Circulating Serum Free Light Chains As
Predictive Markers of AIDS-Related
Lymphoma
• The κ and λ FLCs were both significantly
higher in patients and strongly predicted NHL
in a dose-response manner up to 2 to 5 years
before diagnosis/selection
• © 2010 by American Society of
Clinical Oncology
Miscellaneous
• Increased histiocytes-
– Showing hemophagocytosis.
– Non-caseating granulomas.
– Loose granulomas.
– Triggered by HIV itself.
• Increased number of
histiocytes→hemophagocytic
syndrome→severe pancytopenia.
Miscellaneous
• Pseudogaucher cells-MAC infection.
• Marrow eosinophilia is common: 9-61% of
AIDS patient.
• BM iron stores↑.
• Sideroblasts have been described.
• Granulomas are also infrequent.
BM matrix
• Increased reticulin or fibrosis.
– Focal
– diffuse
• “Gelatinous Transformation”.
• Make aspiration difficult.
Oppurtunistic infections
• Infection
• Mycobacterium avium complex
• Mycobacterium tuberculosis
• Mycobacterium xenopi and kansasi
• Histoplasma
• Cryptococcus
• Toxoplasma
• Cytomegalovirus
• Leishmania
• Pneumocystis carinii
• Disseminated cat scratch
• Parvovirus B 19
MAC
Oppurtunistic infections
• Histology or culture is useful.
• Undiagnosed fever or constitutional
symptoms.
• Low CD4+ count.
• BM cultures as sensitive as blood.
• BM better due special histological staining.
HAART and BM changes
• HAART and immune reconstitution –
increased whole blood count.
• Increase in LTC-IC.
• HAART-
– Controlled HIV replication.
– Restored stem cell activity.

More Related Content

What's hot

Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal HemoglobinuriaDebra G. Carnahan
 
Anemia of Chronic Disease
Anemia of Chronic DiseaseAnemia of Chronic Disease
Anemia of Chronic Disease
Subhash Thakur
 
Bone marrow failure syndromes.ppt
Bone marrow failure syndromes.pptBone marrow failure syndromes.ppt
Bone marrow failure syndromes.ppt
AbdulKaderSouid
 
Hemolytic anemia ppt presentation
Hemolytic anemia ppt presentationHemolytic anemia ppt presentation
Hemolytic anemia ppt presentation
National Academy of Young Scientists
 
Chronic Lymphocytic Leukemia
Chronic Lymphocytic LeukemiaChronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
DrAyush Garg
 
Approach to hemolytic anemias
Approach to hemolytic anemiasApproach to hemolytic anemias
Approach to hemolytic anemias
Dr M Sanjeevappa
 
Approach to pancytopenia
Approach to pancytopeniaApproach to pancytopenia
Approach to microcytic hypochromic anemia
Approach to microcytic hypochromic anemiaApproach to microcytic hypochromic anemia
Approach to microcytic hypochromic anemia
Shinjan Patra
 
Diagnosis of hemolytic anemia
Diagnosis of hemolytic anemiaDiagnosis of hemolytic anemia
Diagnosis of hemolytic anemia
Dr.Amjed Alnatsheh
 
Myeloproliferative Neoplasms
Myeloproliferative NeoplasmsMyeloproliferative Neoplasms
Myeloproliferative Neoplasms
Ayaz Ahmed
 
APPROACH TO PANCYTOPENIA
APPROACH TO PANCYTOPENIA APPROACH TO PANCYTOPENIA
APPROACH TO PANCYTOPENIA
Dr Narendra singh
 
ROLE OF FLOW CYTOMETRY IN LEUKEMIAS
ROLE OF FLOW CYTOMETRY IN LEUKEMIASROLE OF FLOW CYTOMETRY IN LEUKEMIAS
ROLE OF FLOW CYTOMETRY IN LEUKEMIAS
Hajra Mehdi
 
Acute leukemias
Acute leukemiasAcute leukemias
Acute leukemias
Vijay Shankar
 
Approach to hemolytic anemia
Approach to hemolytic anemiaApproach to hemolytic anemia
Approach to hemolytic anemiaSarath Menon
 
Thrombophilia
ThrombophiliaThrombophilia
Thrombophilia
Monkez M Yousif
 
Cell block in cytology
Cell block in cytologyCell block in cytology
Cell block in cytology
Anam Khurshid
 
Investigation of transfusion reaction
Investigation of transfusion reactionInvestigation of transfusion reaction
Investigation of transfusion reaction
SHRUTHI VASAN
 
Transfusion Transmissible Infections
Transfusion Transmissible InfectionsTransfusion Transmissible Infections
Transfusion Transmissible Infections
Rajesh Karyakarte
 
Autoimmune hemolytic anemia
Autoimmune hemolytic anemiaAutoimmune hemolytic anemia
Autoimmune hemolytic anemia
Chetan Ganteppanavar
 

What's hot (20)

Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria
 
Anemia of Chronic Disease
Anemia of Chronic DiseaseAnemia of Chronic Disease
Anemia of Chronic Disease
 
Bone marrow failure syndromes.ppt
Bone marrow failure syndromes.pptBone marrow failure syndromes.ppt
Bone marrow failure syndromes.ppt
 
Hemolytic anemia ppt presentation
Hemolytic anemia ppt presentationHemolytic anemia ppt presentation
Hemolytic anemia ppt presentation
 
Chronic Lymphocytic Leukemia
Chronic Lymphocytic LeukemiaChronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
 
Approach to hemolytic anemias
Approach to hemolytic anemiasApproach to hemolytic anemias
Approach to hemolytic anemias
 
Approach to pancytopenia
Approach to pancytopeniaApproach to pancytopenia
Approach to pancytopenia
 
Approach to microcytic hypochromic anemia
Approach to microcytic hypochromic anemiaApproach to microcytic hypochromic anemia
Approach to microcytic hypochromic anemia
 
Diagnosis of hemolytic anemia
Diagnosis of hemolytic anemiaDiagnosis of hemolytic anemia
Diagnosis of hemolytic anemia
 
Myeloproliferative Neoplasms
Myeloproliferative NeoplasmsMyeloproliferative Neoplasms
Myeloproliferative Neoplasms
 
APPROACH TO PANCYTOPENIA
APPROACH TO PANCYTOPENIA APPROACH TO PANCYTOPENIA
APPROACH TO PANCYTOPENIA
 
ROLE OF FLOW CYTOMETRY IN LEUKEMIAS
ROLE OF FLOW CYTOMETRY IN LEUKEMIASROLE OF FLOW CYTOMETRY IN LEUKEMIAS
ROLE OF FLOW CYTOMETRY IN LEUKEMIAS
 
Acute leukemias
Acute leukemiasAcute leukemias
Acute leukemias
 
Approach to hemolytic anemia
Approach to hemolytic anemiaApproach to hemolytic anemia
Approach to hemolytic anemia
 
Thrombophilia
ThrombophiliaThrombophilia
Thrombophilia
 
Cell block in cytology
Cell block in cytologyCell block in cytology
Cell block in cytology
 
Investigation of transfusion reaction
Investigation of transfusion reactionInvestigation of transfusion reaction
Investigation of transfusion reaction
 
Haemolytic anemia
Haemolytic anemia Haemolytic anemia
Haemolytic anemia
 
Transfusion Transmissible Infections
Transfusion Transmissible InfectionsTransfusion Transmissible Infections
Transfusion Transmissible Infections
 
Autoimmune hemolytic anemia
Autoimmune hemolytic anemiaAutoimmune hemolytic anemia
Autoimmune hemolytic anemia
 

Similar to Hematological manifestations of hiv

EBV susceptibility
EBV susceptibilityEBV susceptibility
ITP by dr. Mohib Ali
ITP by dr. Mohib AliITP by dr. Mohib Ali
ITP by dr. Mohib Ali
Mohib Ali
 
Acute lymphoblastic leukemia
Acute lymphoblastic leukemiaAcute lymphoblastic leukemia
Acute lymphoblastic leukemia
GeneralmedicineAzeez
 
Hiv thrombocytopenia
Hiv thrombocytopeniaHiv thrombocytopenia
Hiv thrombocytopeniaSiva Pesala
 
Thrombocytopenia lecture for v yr mbbs
Thrombocytopenia lecture for v yr mbbsThrombocytopenia lecture for v yr mbbs
Thrombocytopenia lecture for v yr mbbs
mona aziz
 
Chronic Eosinophilia Leukemia (CEL), Keganasan PMN
Chronic Eosinophilia Leukemia (CEL), Keganasan PMNChronic Eosinophilia Leukemia (CEL), Keganasan PMN
Chronic Eosinophilia Leukemia (CEL), Keganasan PMN
ssuser16dac3
 
Blood and its components Part 2
Blood and its components Part 2Blood and its components Part 2
Blood and its components Part 2
Arun Panwar
 
Aplast anemia.pptx
Aplast anemia.pptxAplast anemia.pptx
Aplast anemia.pptx
DrYaqoobBahar
 
Acute Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia
Dr Kartik Kadia
 
Lymphoma
LymphomaLymphoma
Presentation on leukaemia
Presentation on leukaemiaPresentation on leukaemia
Presentation on leukaemia
RakhiYadav53
 
Approach to a bleeding child
Approach to a bleeding childApproach to a bleeding child
Approach to a bleeding child
Dr Jishnu KR
 
MPNs; Definition, Types of MPN Mutations, Aetiology, Clinical features, CML
MPNs; Definition, Types of MPN Mutations, Aetiology,  Clinical features,  CMLMPNs; Definition, Types of MPN Mutations, Aetiology,  Clinical features,  CML
MPNs; Definition, Types of MPN Mutations, Aetiology, Clinical features, CML
Nawsherwan Mohammad
 
primary immunodeficiency HH.pptx
primary immunodeficiency HH.pptxprimary immunodeficiency HH.pptx
primary immunodeficiency HH.pptx
hailuhenock
 
White blood cell disorders
White blood cell disordersWhite blood cell disorders
White blood cell disordersderosaMSKCC
 
02 Aplast anemia.pptx
02 Aplast anemia.pptx02 Aplast anemia.pptx
02 Aplast anemia.pptx
arahmanzai5
 
Leukemia (blood cancer) presentation
Leukemia (blood cancer) presentationLeukemia (blood cancer) presentation
Leukemia (blood cancer) presentation
NehaNupur8
 
Wiskott aldrich syndrome-yashwant kumar
Wiskott aldrich syndrome-yashwant kumarWiskott aldrich syndrome-yashwant kumar
Wiskott aldrich syndrome-yashwant kumarYashwant Kumar
 

Similar to Hematological manifestations of hiv (20)

EBV susceptibility
EBV susceptibilityEBV susceptibility
EBV susceptibility
 
ITP by dr. Mohib Ali
ITP by dr. Mohib AliITP by dr. Mohib Ali
ITP by dr. Mohib Ali
 
Acute lymphoblastic leukemia
Acute lymphoblastic leukemiaAcute lymphoblastic leukemia
Acute lymphoblastic leukemia
 
Hiv thrombocytopenia
Hiv thrombocytopeniaHiv thrombocytopenia
Hiv thrombocytopenia
 
Thrombocytopenia lecture for v yr mbbs
Thrombocytopenia lecture for v yr mbbsThrombocytopenia lecture for v yr mbbs
Thrombocytopenia lecture for v yr mbbs
 
Chronic Eosinophilia Leukemia (CEL), Keganasan PMN
Chronic Eosinophilia Leukemia (CEL), Keganasan PMNChronic Eosinophilia Leukemia (CEL), Keganasan PMN
Chronic Eosinophilia Leukemia (CEL), Keganasan PMN
 
Blood and its components Part 2
Blood and its components Part 2Blood and its components Part 2
Blood and its components Part 2
 
Aplast anemia.pptx
Aplast anemia.pptxAplast anemia.pptx
Aplast anemia.pptx
 
Acute Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Presentation on leukaemia
Presentation on leukaemiaPresentation on leukaemia
Presentation on leukaemia
 
Week 6 presentation
Week 6 presentationWeek 6 presentation
Week 6 presentation
 
approach to MPN
approach to MPNapproach to MPN
approach to MPN
 
Approach to a bleeding child
Approach to a bleeding childApproach to a bleeding child
Approach to a bleeding child
 
MPNs; Definition, Types of MPN Mutations, Aetiology, Clinical features, CML
MPNs; Definition, Types of MPN Mutations, Aetiology,  Clinical features,  CMLMPNs; Definition, Types of MPN Mutations, Aetiology,  Clinical features,  CML
MPNs; Definition, Types of MPN Mutations, Aetiology, Clinical features, CML
 
primary immunodeficiency HH.pptx
primary immunodeficiency HH.pptxprimary immunodeficiency HH.pptx
primary immunodeficiency HH.pptx
 
White blood cell disorders
White blood cell disordersWhite blood cell disorders
White blood cell disorders
 
02 Aplast anemia.pptx
02 Aplast anemia.pptx02 Aplast anemia.pptx
02 Aplast anemia.pptx
 
Leukemia (blood cancer) presentation
Leukemia (blood cancer) presentationLeukemia (blood cancer) presentation
Leukemia (blood cancer) presentation
 
Wiskott aldrich syndrome-yashwant kumar
Wiskott aldrich syndrome-yashwant kumarWiskott aldrich syndrome-yashwant kumar
Wiskott aldrich syndrome-yashwant kumar
 

More from Appy Akshay Agarwal

Urine analysis in pathology clinical
Urine analysis in pathology clinical Urine analysis in pathology clinical
Urine analysis in pathology clinical
Appy Akshay Agarwal
 
Pre leukemia MDS
Pre leukemia MDSPre leukemia MDS
Pre leukemia MDS
Appy Akshay Agarwal
 
IgG4 related disorders of the eye
IgG4 related disorders of the eyeIgG4 related disorders of the eye
IgG4 related disorders of the eye
Appy Akshay Agarwal
 
Necrosis & gangrene pathology calcification
Necrosis & gangrene pathology calcificationNecrosis & gangrene pathology calcification
Necrosis & gangrene pathology calcification
Appy Akshay Agarwal
 
Hypersensitivity reaction pathology microbiology immunity
Hypersensitivity reaction  pathology microbiology immunityHypersensitivity reaction  pathology microbiology immunity
Hypersensitivity reaction pathology microbiology immunity
Appy Akshay Agarwal
 
Histotechnique for practicals pathology
Histotechnique for practicals pathologyHistotechnique for practicals pathology
Histotechnique for practicals pathology
Appy Akshay Agarwal
 
Fungus in histopathology
Fungus in histopathologyFungus in histopathology
Fungus in histopathology
Appy Akshay Agarwal
 
Fungal infections in histopathology
Fungal infections in histopathologyFungal infections in histopathology
Fungal infections in histopathology
Appy Akshay Agarwal
 
Diseases of blood vessels
Diseases of blood vesselsDiseases of blood vessels
Diseases of blood vessels
Appy Akshay Agarwal
 
Coagulation profile and its uses
Coagulation profile and its usesCoagulation profile and its uses
Coagulation profile and its uses
Appy Akshay Agarwal
 
Cerebrovascular disease pathology stroke
Cerebrovascular disease pathology strokeCerebrovascular disease pathology stroke
Cerebrovascular disease pathology stroke
Appy Akshay Agarwal
 
Blood products separation and quality control
Blood products separation and quality controlBlood products separation and quality control
Blood products separation and quality control
Appy Akshay Agarwal
 
Blood component preparation blood banking
Blood component preparation blood bankingBlood component preparation blood banking
Blood component preparation blood banking
Appy Akshay Agarwal
 
Blood coagulation and physiology
Blood coagulation and physiologyBlood coagulation and physiology
Blood coagulation and physiology
Appy Akshay Agarwal
 
Benign inclusions in lymph nodes histopathology
Benign inclusions in lymph nodes histopathologyBenign inclusions in lymph nodes histopathology
Benign inclusions in lymph nodes histopathology
Appy Akshay Agarwal
 
Barrett oesophagus journal club pathology
Barrett oesophagus journal club pathologyBarrett oesophagus journal club pathology
Barrett oesophagus journal club pathology
Appy Akshay Agarwal
 
Atherosclerosis pathology mbbs
Atherosclerosis pathology mbbsAtherosclerosis pathology mbbs
Atherosclerosis pathology mbbs
Appy Akshay Agarwal
 
Antibody mediated rejection pathology histopathology
Antibody mediated rejection pathology histopathologyAntibody mediated rejection pathology histopathology
Antibody mediated rejection pathology histopathology
Appy Akshay Agarwal
 
Immunohistochemistry in pathology laboratory
Immunohistochemistry in pathology laboratoryImmunohistochemistry in pathology laboratory
Immunohistochemistry in pathology laboratory
Appy Akshay Agarwal
 
introduction of cytopathology
introduction of cytopathologyintroduction of cytopathology
introduction of cytopathology
Appy Akshay Agarwal
 

More from Appy Akshay Agarwal (20)

Urine analysis in pathology clinical
Urine analysis in pathology clinical Urine analysis in pathology clinical
Urine analysis in pathology clinical
 
Pre leukemia MDS
Pre leukemia MDSPre leukemia MDS
Pre leukemia MDS
 
IgG4 related disorders of the eye
IgG4 related disorders of the eyeIgG4 related disorders of the eye
IgG4 related disorders of the eye
 
Necrosis & gangrene pathology calcification
Necrosis & gangrene pathology calcificationNecrosis & gangrene pathology calcification
Necrosis & gangrene pathology calcification
 
Hypersensitivity reaction pathology microbiology immunity
Hypersensitivity reaction  pathology microbiology immunityHypersensitivity reaction  pathology microbiology immunity
Hypersensitivity reaction pathology microbiology immunity
 
Histotechnique for practicals pathology
Histotechnique for practicals pathologyHistotechnique for practicals pathology
Histotechnique for practicals pathology
 
Fungus in histopathology
Fungus in histopathologyFungus in histopathology
Fungus in histopathology
 
Fungal infections in histopathology
Fungal infections in histopathologyFungal infections in histopathology
Fungal infections in histopathology
 
Diseases of blood vessels
Diseases of blood vesselsDiseases of blood vessels
Diseases of blood vessels
 
Coagulation profile and its uses
Coagulation profile and its usesCoagulation profile and its uses
Coagulation profile and its uses
 
Cerebrovascular disease pathology stroke
Cerebrovascular disease pathology strokeCerebrovascular disease pathology stroke
Cerebrovascular disease pathology stroke
 
Blood products separation and quality control
Blood products separation and quality controlBlood products separation and quality control
Blood products separation and quality control
 
Blood component preparation blood banking
Blood component preparation blood bankingBlood component preparation blood banking
Blood component preparation blood banking
 
Blood coagulation and physiology
Blood coagulation and physiologyBlood coagulation and physiology
Blood coagulation and physiology
 
Benign inclusions in lymph nodes histopathology
Benign inclusions in lymph nodes histopathologyBenign inclusions in lymph nodes histopathology
Benign inclusions in lymph nodes histopathology
 
Barrett oesophagus journal club pathology
Barrett oesophagus journal club pathologyBarrett oesophagus journal club pathology
Barrett oesophagus journal club pathology
 
Atherosclerosis pathology mbbs
Atherosclerosis pathology mbbsAtherosclerosis pathology mbbs
Atherosclerosis pathology mbbs
 
Antibody mediated rejection pathology histopathology
Antibody mediated rejection pathology histopathologyAntibody mediated rejection pathology histopathology
Antibody mediated rejection pathology histopathology
 
Immunohistochemistry in pathology laboratory
Immunohistochemistry in pathology laboratoryImmunohistochemistry in pathology laboratory
Immunohistochemistry in pathology laboratory
 
introduction of cytopathology
introduction of cytopathologyintroduction of cytopathology
introduction of cytopathology
 

Recently uploaded

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 

Recently uploaded (20)

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 

Hematological manifestations of hiv

  • 1. HEMATOLOGICAL MANIFESTATIONS OF HIV-AIDS Maj Shilpi Singh Guide: Col Sonia Badwal
  • 2. • A 48-year-old woman • Presentation – severe epistaxis. – hematologic profile • marked thrombocytopenia (3 x 109/L) • hemoglobin 11.6 g/dL, • leukocyte count 5.2 x 109/L • unremarkable blood film except for rare platelets. – tested positive for HIV • CD4 count was low (20/mm3). – tentative diagnosis HIV–immune thrombocytopenic purpura (ITP) – treated with • antiretroviral medications, • IVIG,
  • 3. – No improvement. – After 6 weeks bone marrow examination done. • The aspirate was dry. – core biopsy • hypercellular marrow with heavy infiltrate of Mycobacterium avium intracellulare infection – started on 4-drug antituberculosis treatment, – 2 weeks later her platelet count was 30 x 109/L. – platelet count steadily rose to 150 x 109/L by day 20 and was maintained thereafter
  • 4. CASE 2 AFMC NOV 2008 26 yr old lady presented with Fever , Low backache and significant weight loss with past history of cervical Lymphadenitis & exposure to ATT( 2006) . Spleen palpable 03cm below LCM ,firm, non tender • Hb - 10.3gm/dl • TLC - 7600 / cumm • DLC - P 68L24 M03 E 05 • Platelets - 2.3 x 106 / μL • PBS - Microcytic hypochromic picture • ESR (wg) - 18mm fall in 1st hr
  • 5. • Spinal Abnormality, kyphosis and gibbus abnormalities present • Put on ATT again at Kolhapur • Presented to us in Nov 2008 with severe pancytopenia requiring multiple transfusions • BM asp BM biopsy suggestive of anaemia of critically ill and showed florid gelatinous degeneration • Thus tested for HIV and found to be positive
  • 6.
  • 7. What is AIDS • an HIV infection • any of the disorders in clinical category B or C of HIV infection. – Serious opportunistic infections – cancers, such as Kaposi's sarcoma and non-Hodgkin lymphoma, to which defective cell-mediated immunity predisposes – Neurologic dysfunction • or a CD4+ T lymphocyte count of < 200/μL. CDC disease staging system (most recently revised in 1993)
  • 8. Contents • Hematological Manifestations. • BM Manifestations. • HIV associated lymphomas.
  • 9. Hematological Manifestations • Cytopenias – Anaemia – Neutropenia – Thrombocytopenia • Thrombotic thrombocytopenic purpura. • Coagulopathies and coagulation disorders
  • 10. Anaemia • Most common. • Throughout the course of illness. • ART can cause improvement in Hb levels. • Increased risk of disease progression. • Shorter survival. • Decreased quality of life.
  • 11. Etiopathogenesis • HIV induced effect on bone marrow. – Ineffective erythropoesis. – Infection of progenitor cells. – Negative effect on EPO. • Nutritional deficiency. – Fe, B12, Folate. • Infiltration of BM- infections or tumors. • Medications.
  • 12. Etiopathogenesis (contd) • Hemolytic anaemia. – Intrinsic red cell defect – Extrinsic red cell defect DCT positive • Both warm and cold AIHA. • Increased risk of thromboembolism. • Thrombocytopenia and fragmented cells in PBS. • Bleeding. – GI bleeding due to CMV, NHLs and kaposi.
  • 13. Lab investigations • PBS- – Macrocytosis due to AZT. – Normocytic due to HIV infection. – Schistocytes . • Fe indices- – Low serum Fe and transferrin and high serum ferritin. – BM Fe increased
  • 14. Lab investigations (contd) • Positive DAT- – 20-43% of hospitalised patients of AIDS. – Cold agglutinins in 22%. • B12 levels low. • Folate levels are normal. • EPO levels are- – Low due to post-translational events. – High in patients with zidovudine associated anaemia.
  • 15. Leukopenia • Lymphopenia and neutropenia commonly. • Impaired granulopoesis. • Neutropenia due to drugs- – Pentamidine, gancyclovir, zidovudine. • Autoimmune distruction. • PBS – – hypopigmentation, shift to left, pseudo-pelger huet and other dysplastic changes. • Neutrophil function abnormalities.
  • 16. Thrombocytopenia • <100,000/mm3. • 3-8% of HIV positive and 30-45% of AIDS. • Neither a prognostic indicator nor a sign for progression. • Any stage of disease. • Rarely significant bleeding problem. • Responds to ART.
  • 17. Etiopathogenesis • Platelet destruction in early course. • Reduced production in later course. • Causes- – Chronic ITP-megakaryocytic . • Elevated platelet associated antibodies. GpIIIa • Cross reactivity between anti-HIV and platelet antigens. – Impaired thrombopoesis- • Depressed marrow platelet production. • Low MPV and dyspoetic – Drug induced
  • 18. TTP • Pentad of fever, neurological deficit, thrombocytopenia, oliguria and microangiopathy. • PBS-schistocytes, reticulocytosis. • Indirect hyperbilirubinaemia, raised LDH. • Precipitated by-infection, drugs, pregnancy etc. • More in era before HAART.
  • 19. Etiopathogenesis • Absence of vWF cleaving protease activity. • In HIV the cause is IgG autoantibody against the enzyme. • Common coexistence of AIDS defining illnesses. • CD4+<250/mm3. • TTP should always be in the list.
  • 20. Coagulation Disorders • HIV is a prothrombotic condition. • Low CD4+ count and protease inhibitors are the culprits. • Coexistent-APLA, LA, Protein C and S deficiency, malignancies, autoimmune disorders. • Endothelial damage due to tumor cells.
  • 21. Other coagulation protein abnormalities • Heparin cofactor II deficiency. • AT deficiency is reported in HIV patients- – Malnutrition – Protein loosing nephropathy. • Prevalance – LA=53-70% – anti-cardiolipin antibodies=46-90%. • Infections like Hep C, syphilis, PCP cause production of antibodies.
  • 22. Role of protease inhibitors • Abnormalities of glucose metabolism and serum lipids. • Disturbances of fibrinolysis.
  • 24. Bone Marrow • Cytological features – M/E ratio 2-5:1 – Hypercellular, – normocellular or hypocellular – Erythroid dysplasia – Erythroid hypoplasia • MAC infection,
  • 25. Bone Marrow • Myeloid dysplasia – Left-shifted, – hyposegmented, – maturation arrest at metamyelocyte stage • Megakaryocytes – Adequate to increased – Dysplastic – hyposegmented, – Micro megakaryocytes denuded nuclei.
  • 26. Bone Marrow • Plasmacytosis • Lymphoid aggregates/infiltrates • Histiocytes • “Loose granulomas” (aggregates of plasma cells, lymphocytes, histiocytes) • Erythrophagocytosis
  • 27. Bone Marrow • Increased eosinophils • Iron adequate to increased (reticulo- endothelial cell distribution) • Marrow Increased reticulin • Matrix Necrosis • Serous atrophy
  • 28. Etiopathogenesis • Infection of MSCs with HIV- – Abrogates growth – Hematopoetic supportive function. • Defective progenitor growth- – Secondary to suppressor T-cell. – Inversely proportional to T4 to T8 ratio. • CD34 progenitor cell – infected with HIV.
  • 29. Etiopathogenesis • HIV infection of Monocyte/Macrophage- – Exaggerated TNF, IL-1 and TGF-b – Development of immunodeficiency. – HIV-1 dementia. • HIV infection of microvascular endothelial cells- – Poor response to IL-1a. – Impaired release of IL-6 and G-CSF
  • 30. Dyserythropoesis • Most common, includes- – Changes in erythroblasts – • Lobulations • Binucleation and fragmentation- • Basophilic stippling in later stages. • Florid megaloblastic changes • Unrelated to B12, folate and drugs. – Erythroid hypoplasia- • In AIDS, ARC, Ziduvudine and MAC infection. • PRCA secondary to parvovirus B19.
  • 32. Dysmegakaryopoesis • Can be with or without thrombocytopenia. • Dysplastic changes- – Micromegs with denuded nuclei – Hyposegmented megs – Fragmented nuclei – Clustering of megs. • Dysplastic changes and presence of HIV RNA in megs
  • 33.
  • 34. Cellularity • BM is difficult to aspirate. – Focal or diffuse increase in reticulin • Normo to hypercellular. – Myeloid dysplasia – Ineffective erythropoesis • M:E ratio of 2-7:1 – Myeloid hyperplasis – Erythroid hypoplasia.
  • 35. Plasma cell abnormalities • Increase seen in 31-85% people. • Due to- – Physiological response to antigenic stimulation. – Dysregulated B-cell proliferation. – Seen in all stages. • Morphology – Dysplasia, large bi or tri nucleate – In clusters
  • 36. Plasma cell abnormalities • Russel bodies, multiple globules. • Myeloma is clearly reported in AIDS. • Monoclonal spikes on serum electrophoresis. • Marrow plasmacytosis • Atypical forms. • Without demonstration of clonality. • Paraproteinemia activity against HIV gag & pol Vigrous immune response to HIV.
  • 37. Lymphoid aggregates • 10-50% of patients of AIDS-ARC. • Small, round, well circumscribed- small lymphocytes. • Large poorly defined mixed with histiocytes. • Atypical, cleaved lymphocytes-paratrabecular
  • 39. Lymphoma • 80% peripheral, 20% arise in CNS. • Aggressive B-cell lymphoma. • PCNSL • Primary effusion Lymphoma. • Plasmblastic multicentric Castleman disease. • Hodgkin Lymphoma.
  • 40. Why HIV- Associated • Sharp decline post HAART • Similar geographic distribution • Same risk group individuals • Not responding to chemo as other lymphomas • More extranodal spread , BM commonest
  • 41. HIV –associated lymphomas • Co-infection with HIV and KSHV/HHV-8 • Liquid phase • No masses or adenopathy • Fever, night sweats, weight loss and hepatosplenomegaly.
  • 42. Aggressive B-cell lymphomas • DLBCL • B-cell immunoblastic lymphomas • Small non-cleaved lymphoma – Burkitt – Burkitt-like.
  • 43. Plasmablastic lymphoma • Cells resemble B-immunoblasts • Immunphenotypically plasma cells • Highest incidence in HIV-patients • Mass in oral cavity, extranodal sites • Diffuse and cohesive proliferation • EBV associated • CD 38,138 positive-CD 45,20 negative.
  • 44.
  • 45. PCNSL • CD4< 50. • Also large cell lymphomas • EBV associated • Lack c-myc translocation • Responds well to HAART.
  • 46. HIV associated HD • HD not a part of CDC definition • More aggressive, extranodal, BM involvment • Less mediastinal adenopathy • Mixed cellularity or LDHL • CD4< 300/dl
  • 48. ROLE OF FLCs • Circulating Serum Free Light Chains As Predictive Markers of AIDS-Related Lymphoma • The κ and λ FLCs were both significantly higher in patients and strongly predicted NHL in a dose-response manner up to 2 to 5 years before diagnosis/selection • © 2010 by American Society of Clinical Oncology
  • 49. Miscellaneous • Increased histiocytes- – Showing hemophagocytosis. – Non-caseating granulomas. – Loose granulomas. – Triggered by HIV itself. • Increased number of histiocytes→hemophagocytic syndrome→severe pancytopenia.
  • 50.
  • 51. Miscellaneous • Pseudogaucher cells-MAC infection. • Marrow eosinophilia is common: 9-61% of AIDS patient. • BM iron stores↑. • Sideroblasts have been described. • Granulomas are also infrequent.
  • 52.
  • 53. BM matrix • Increased reticulin or fibrosis. – Focal – diffuse • “Gelatinous Transformation”. • Make aspiration difficult.
  • 54.
  • 55. Oppurtunistic infections • Infection • Mycobacterium avium complex • Mycobacterium tuberculosis • Mycobacterium xenopi and kansasi • Histoplasma • Cryptococcus • Toxoplasma • Cytomegalovirus • Leishmania • Pneumocystis carinii • Disseminated cat scratch • Parvovirus B 19
  • 56. MAC
  • 57. Oppurtunistic infections • Histology or culture is useful. • Undiagnosed fever or constitutional symptoms. • Low CD4+ count. • BM cultures as sensitive as blood. • BM better due special histological staining.
  • 58.
  • 59.
  • 60. HAART and BM changes • HAART and immune reconstitution – increased whole blood count. • Increase in LTC-IC. • HAART- – Controlled HIV replication. – Restored stem cell activity.

Editor's Notes

  1. A 48-year-old woman presented with severe epistaxis. Her hematologic profile showed marked thrombocytopenia (3 x 109/L), hemoglobin 11.6 g/dL, leukocyte count 5.2 x 109/L, and an unremarkable blood film except for rare platelets. She tested positive for HIV and the CD4 count was low (20/mm3). A tentative diagnosis of HIV–immune thrombocytopenic purpura (ITP) was made. She was treated with antiretroviral medications, IVIG, and subsequently with steroids for 4 weeks without improvement. Rituximab was deemed unsafe because of her immunosuppressed status. After 6 weeks of platelet unresponsiveness, a bone marrow examination was performed. The aspirate was dry. The core biopsy showed a hypercellular marrow with a heavy infiltrate of Mycobacterium avium intracellulare infection (ZN stain in figure). She was started on 4-drug antituberculosis treatment, and 2 weeks later her platelet count was 30 x 109/L. The platelet count steadily rose to 150 x 109/L by day 20 and was maintained thereafter
  2. So the first lesson learnt is there is more to HIV than eye can see.
  3. Retroviruses are enveloped RNA viruses defined by their mechanism of replication via reverse transcription to produce DNA copies that integrate in the host cell genome.
  4. CDC A#, B3, C1, C2 and C3 are AIDs classifies AIDS as an HIV infection with CD4 cell count of less than 200 and those with certain HIV related conditions and symptoms. WHO classification is used in resource strained settings and defines AIDS categories on the basis of clinical manifestations. CDC (Central of disease control) CD4 normal 400-1500.
  5. Philia- affinity
  6. BM supression through abnormal cytokine production and alteration in BM microenvironment. Can be both reduced intake or absorption. Infections like MAC, PCP, histoplasma, parvovirus. Kaposi sarcoma and NHLs. Zidovudine, septran, ganciclovir, amphotericin B.
  7. Mechanisms proposed for AIHA include antierythrocyte antibodies, non-specific coating of red cells by Ig, presence of immune complexes and abnormal B cell regulation.
  8. Direct hiv effect, oppurtunistic inf and neoplasia megalocytes, increased granulation and peroxidase activity phacocytic and intracellular killing of microbes is affected
  9. HIV INFECTION SHOULD BE SUSPECTED IN PATIENTS PRESENTING WITH UNEXPLAINED THROMBOCYTOPENIA.
  10. Megakaryocytes bear CD4 receptor. Platelet destruction due to antibodies, infections, sple3nomegaly and fever. Production reduces due to reduced CD34 and megakaryoctic diffrentiation.
  11. In patients with asymptomatic HIV infection response to therapy is similar to that seen in HIV negative persons, however in those with advanced HIV disease outcome is often dismal.
  12. Inability to cleave high molecular wt vWF synthesized by endothelial cells. Like pcp, kaposi, cryptococcus and CMV. Of treating physicians as plasmapheresis provides substantial symptomatic relief .
  13. Ad fuel to the fire.
  14. Is more prevalent in hiv. It is a specific thrombin inhibitor whose inhibitory activity is enhanced by heparin and deficiency causes recurrent thrombosis.
  15. One should be alert about the possibility of unprovoked thrombosis in patients of HIV infection and possibility of increased lipid levels in patients on protease inhibitors.
  16. Hiv infection of stromal cells produces inhibitory factors which suppresses clonogenic potential of MSC. There is now ample evidence that CD34 progenitor cells can be infected by HIV
  17. However these may accentuate it.
  18. Dyserythropoiesis with megaloblastic changes and nuclear bridging in MDS associated with previous high BZ exposure. Bone marrow aspirate with Wright–Giemsa stain (original magnification 1000×). Reproduced with permission [11].
  19. Ultrastructural changes are marked balloning and blebbing of peripheral zone…….as seen in myeloproliferative neoplasms……..along with clinical response to patients with Zidovudine are all consistent with the view meg itself is the target for Hiv infection.
  20. True marrow cellularity is appreciated on trephine biopsy…….even in the setting of peripheral cytopenias in a majority of patients…therefore hypercellularity of the marrow in the face on cytopenias is common in HIV
  21. By viruses and other antigenic stimulation or may be secondary to.
  22. In paratrabecular localization it is important to r/o NHL, since lymphoma in AIDS patients is commoner than benign lymphoid aggregates.
  23. AIDS was first described in 1981 and in 1985 CDC included HIV patients with aggressive B-cell NHL, also as AIDS. Currently The list is not exhaustive and includes
  24. PEL and PMCD…..spreading along serous membranes.
  25. Aggressive B-cell lymphomas include………DLBCL is centroblastic /immunoblastic…….Burkitt is classical/BL with plasmacytoid diffrentiation and atypical BL
  26. Like mucosal membranes, including sinonasal cavity, bone marrow and skin. Plasmablastic lymphomas not associated with HIV are common in lymphnodes. High proliferation index Ki-67 &amp;gt;90%
  27. Plasmablastic Lymphoma: This aggressive variant of diffuse large B-cell lymphoma usually occurs in the oral cavity of HIV positive patients, monomorphic population of large immunoblastic population with prominent nucleoli….. Starry sky pattern.
  28. Becoz of no clear demonstration of its increased incidence in conjunction.
  29. Hodgkin lymphoma infiltration of the bone marrow. A Reed-Sternberg cell is highlighted by the black arrow. Malignant bone marrow infiltrations often present with cytopenias.
  30. HIV-infected persons have an elevated risk of developing non-Hodgkin&amp;apos;s lymphoma (NHL); this risk remains increased in the era of effective HIV therapy. We evaluated serum immunoglobulin (Ig) proteins as predictors of NHL risk among HIV-infected individuals. DUE TO DYSREGULATED B-CELL FUNCTION
  31. Aggregates of histiocytes, plasma cells and lymphocytes……...no obvious second infection, HIV itself triggered histiocyte proliferation and phagocytosis.
  32. Hematophagocytosis accompanying MDS-Eo associated with previous high BZ exposure. Activated histiocytic cells exhibit prominent phagocytosis of degenerating erythroid granulocytic cells typical of an immune-mediated inflammatory process. Bone marrow aspirate with Wright–Giemsa stain (original magnification 1000×). Reproduced with permission [11].
  33. In …which foamy histiocytes were described on Giemsa stain….. Although peripheral blood eosiniphiliais rarely seen….…indicating a defect in Fe utilization…….but are uncommon.
  34. Also called serous atrophy.
  35. Bone marrow biopsies from post-transplant, immunocompromised patients are evaluated for the presence of primary marrow defects (eg. drug induced cytopenias), infiltrative processes (eg. metastatic carcinoma and epstein-barr virus-related post-transplant lymphoproliferative disorder), and opportunistic infections (eg. fungal, viral, mycobacterial). Although the bone marrow biopsy from this patient is insufficient to assess hematopoiesis, numerous loose collections of foamy macrophages were identified. Special stains for acid fast bacilli [inset] revealed the presence of abundant mycobacteria. Given the clinical history and the number of mycobacteria seen, this finding supports the diagnosis of infection with mycobacterium avium complex (MAC).
  36. cryptococcus
  37. Long term culture initiating cells…………in experiments .Probably by supressing cytokines which inhibit normal hematopoesis